A5025675403- Mental Health Treatment and Access
- Child and Adolescent Psychosocial and Emotional Development
- Health disparities and outcomes
- Child and Adolescent Health
- Health Systems, Economic Evaluations, Quality of Life
- Migration, Health and Trauma
- Maternal Mental Health During Pregnancy and Postpartum
- Schizophrenia research and treatment
- COVID-19 and Mental Health
- Family Caregiving in Mental Illness
- Mental Health and Psychiatry
- Global Maternal and Child Health
- Suicide and Self-Harm Studies
- Digital Mental Health Interventions
- Psychiatric care and mental health services
- Adolescent and Pediatric Healthcare
- Substance Abuse Treatment and Outcomes
- Health, psychology, and well-being
- Psychosomatic Disorders and Their Treatments
- Resilience and Mental Health
- Chronic Disease Management Strategies
- Global Public Health Policies and Epidemiology
- Employment and Welfare Studies
- Epilepsy research and treatment
- Health Policy Implementation Science
Harvard Global Health Institute
2019-2024
Harvard University
2018-2024
Centre for Addiction and Mental Health
2024
Curtin University
2024
International Drug Development
2024
UNSW Sydney
2024
University of Glasgow
2024
University of Helsinki
2024
University of Massachusetts Amherst
2024
World Federation for Mental Health
2023
Objective To describe the development of World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for measuring functioning and disability in accordance with International Classification Functioning, Health.WHODAS is a standard metric ensuring scientific comparability across different populations.Methods A series studies was carried out globally.Over 65 000 respondents drawn from general population specific patient populations were interviewed by trained interviewers who...
Depression and anxiety disorders are highly prevalent disabling disorders, which result not only in an enormous amount of human misery lost health, but also economic output. Here we propose a global investment case for scaled-up response to the public health burden depression disorders.In this return on analysis, used mental module OneHealth tool calculate treatment costs outcomes 36 countries between 2016 2030. We assumed linear increase coverage. factored modest improvement 5% both ability...
Excess mortality in persons with severe mental disorders (SMD) is a major public health challenge that warrants action. The number and scope of truly tested interventions this area remain limited, strategies for implementation scaling up programmes strong evidence base are scarce. Furthermore, the majority available focus on single or an otherwise limited risk factors. Here we present multilevel model highlighting factors excess SMD at individual, system socio‐environmental levels. Informed...
The COVID-19 pandemic has had an unprecedented impact on health systems in most countries, and particular, the mental well-being of workers frontlines response efforts. purpose this article is to provide evidence-based overview adverse impacts healthcare during times crisis other challenging working conditions highlight importance prioritizing protecting workforce, particularly context pandemic. First, we a broad elevated risk stress, burnout, moral injury, depression, trauma, challenges...
Following approval of the ICD‐11 by World Health Assembly in May 2019, Organization (WHO) member states will transition from ICD‐10 to ICD‐11, with reporting health statistics based on new system begin January 1, 2022. The WHO Department Mental and Substance Abuse publish Clinical Descriptions Diagnostic Guidelines (CDDG) for Mental, Behavioural Neurodevelopmental Disorders following ICD‐11’s approval. development CDDG over past decade, principles clinical utility global applicability, has...
Crick Lund and colleagues describe their plans for the PRogramme Improving Mental health carE (PRIME), which aims to generate evidence on implementing scaling up integrated packages of care priority mental disorders in primary maternal contexts Ethiopia, India, Nepal, South Africa, Uganda.